Abstract

Neurotrophins, such as nerve growth factor and brain-derived neurotrophic factor, activate Trk receptor tyrosine kinases through receptor dimerization at the cell surface followed by autophosphorylation and recruitment of intracellular signaling molecules. The intracellular pathways used by neurotrophins share many common protein substrates that are used by other receptor tyrosine kinases (RTK), such as Shc, Grb2, FRS2, and phospholipase C-gamma. Here we describe a novel RTK mechanism that involves a 220-kilodalton membrane tetraspanning protein, ARMS/Kidins220, which is rapidly tyrosine phosphorylated in primary neurons after neurotrophin treatment. ARMS/Kidins220 undergoes multiple tyrosine phosphorylation events and also serine phosphorylation by protein kinase D. We have identified a single tyrosine (Tyr(1096)) phosphorylation event in ARMS/Kidins220 that plays a critical role in neurotrophin signaling. A reassembled complex of ARMS/Kidins220 and CrkL, an upstream component of the C3G-Rap1-MAP kinase cascade, is SH3-dependent. However, Tyr(1096) phosphorylation enables ARMS/Kidins220 to recruit CrkL through its SH2 domain, thereby freeing the CrkL SH3 domain to engage C3G for MAP kinase activation in a neurotrophin dependent manner. Accordingly, mutation of Tyr(1096) abolished CrkL interaction and sustained MAPK kinase activity, a response that is not normally observed in other RTKs. Therefore, Trk receptor signaling involves an inducible switch mechanism through an unconventional substrate that distinguishes neurotrophin action from other growth factor receptors.

Highlights

  • Like other receptor tyrosine kinases, Trk receptors are activated after ligand-induced dimerization

  • ARMS Is Tyrosine-phosphorylated at Tyr1096 in Response to Neurotrophins—ARMS is phosphorylated on many tyrosine residues in response to neurotrophins [11, 12]

  • An increase in the level of phosphorylated ARMS protein was observed upon nerve growth factor (NGF) treatment in PC12 cells (2.6-fold) and brain-derived neurotrophic factor (BDNF) treatment of cortical neurons (3.1-fold) (Fig. 1A)

Read more

Summary

Introduction

Like other receptor tyrosine kinases, Trk receptors are activated after ligand-induced dimerization. Our data support a model in which a constitutive association of Trk receptors, ARMS and CrkL, is altered by a switch in the motif recognition of adaptor molecules after neurotrophin treatment. The phosphorylation of a specific tyrosine residue in ARMS allows the adaptor protein CrkL to engage C3G and activate Rap1.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call